- Sogawa K, Yonekubo R, Shimizu M, Muraoka S, Adachi J, Takano S, Takizawa H, Ohtsuka M, Tomonaga T. Serum fucosylated receptor expression-enhancing protein 5 as a biomarker for early stage pancreatic cancer. Oncol Lett. 2025 Sep 26;30(6):556. DOI: 10.3892/ol.2025.15302.
- Shirai Y, Enomoto T, Takeda Y, Edahiro R, Takahashi-Itoh M, Noda Y, Adachi Y, Nakayama M, Kawasaki T, Koba T, Futami Y, Yoshimura H, Amiya S, Hara R, Yamamoto M, Nakatsubo D, Suga Y, Naito M, Masuhiro K, Matsuki T, Hirata H, Iwahori K, Nagatomo I, Miyake K, Koyama S, Fukushima K, Shiroyama T, Naito Y, Futami S, Natsume-Kitatani Y, Ose N, Funaki S, Nojima S, Shichino S, Yanagawa M, Shintani Y, Nogami-Itoh M, Adachi J, Inoue Y, Tomonaga T, Okada Y, Mizuguchi K, Kumanogoh A. Serum vesicle biomarkers reflect the disease activity of idiopathic pulmonary fibrosis. J Transl Med. 2025 Oct 15;23(1):1102. DOI: 10.1186/s12967-025-07011-2.
- Iwahara N, Muraoka S, Saito T, Hirano M, Yokokawa K, Tanemoto M, Oda R, Nonaka T, Suzuki S, Adachi J, Hisahara S. Elevated ITGAX/CD11c in CSF-Derived Extracellular Vesicles Reflects Disability Progression in Multiple Sclerosis. Neurol Neuroimmunol Neuroinflamm. 2025 Sep;12(5):e200442. DOI: 10.1212/nxi.000000000020
- Yoshii K, Node E, Furuta M, Tojima Y, Matsunaga A, Adachi J, Takaai N, Morita M, Hosomi K, Kunisawa J. Establishment of enterotype-specific antibodies for various diagnostic systems. Sci Rep. 15(1):16814. 2025. DOI: 10.1038/s41598-025-01144-6.
- Tomiyama E, Fujita K, Matsuzaki K, Narumi R, Matsushita M, Hayashi Y, Hashimoto M, Kato T, Hatano K, Kawashima A, Minami T, Takao T, Takada S, Uemura H, Adachi J, Tomonaga T, Nonomura N. EIF2S1 in Urinary Extracellular Vesicles as a Novel Diagnostic Marker for Bladder Cancer. Cancer Med. 14(10):e70964. 2025. DOI: 10.1002/cam4.70964.
